Decoy Therapeutics DCOY
NASDAQ DCOY
$1.08 -0.06 (-5.29%)
As of: Oct 21, 2026 · 3:55 PM EDT

Decoy Therapeutics (DCOY) Debt Ratio (2019 - 2026)

Updated

Decoy Therapeutics' Debt Ratio came in at 0.05 for Q1 2025, up 100.5% from 0.02 a year earlier but down 34.6% from the prior quarter.

Analysis

Decoy Therapeutics (DCOY) Debt Ratio (2019 - 2026) Analysis & Trends

For FY2024, Decoy Therapeutics' Debt Ratio was 0.07, up 61.1% from FY2023.

  • Going back by year, Debt Ratio was 0.05 in FY2023 and 0.02 in FY2020 (-44.5%).
  • The five-year range for quarterly Debt Ratio is 0.00 (Q1 2021) to 0.09 (Q3 2024).
  • Year-over-year, Debt Ratio has increased for three consecutive quarters.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 0.39
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 0.24
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 0.52
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 0.42
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 0.08
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 0.28
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 0.60
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 0.53
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 0.31
10 Decoy Therapeutics 571,865.63 -31.06 Mn - 0.02
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 0.02
Mar 31, 2026 0.02
Dec 31, 2025 0.01
Mar 31, 2025 0.05
Dec 31, 2024 0.07
Sep 30, 2024 0.09
Mar 31, 2024 0.02
Dec 31, 2023 0.05
Sep 30, 2023 0.06
Mar 31, 2021 0.00
Dec 31, 2020 0.02
Sep 30, 2020 0.03
Mar 31, 2020 0.01
Dec 31, 2019 0.04
Sep 30, 2019 0.05
API Access

Decoy Therapeutics Debt Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=debt-ratio&ticker=DCOY&period=max&api_key=YOUR_API_KEY